Advanced search
Publication Cover
Leukemia & Lymphoma Volume 44, 2003 - Issue 1
Submit an article Journal homepage
17
Views
6
CrossRef citations to date
0
Altmetric
Research Article

The Effects of the Farnesyl Transferase Inhibitor FTI L-778,123 on Normal, Myelodysplastic, and Myeloid Leukemia Bone Marrow Progenitor Proliferation In Vitro

X.-K. Huang Rush Cancer Institute, 1725 West Harrison Street, Suite 809 Professional Building I, Chicago, IL 60612, USA
,
P. Meyer Rush Cancer Institute, 1725 West Harrison Street, Suite 809 Professional Building I, Chicago, IL 60612, USA
,
B. Li Rush Cancer Institute, 1725 West Harrison Street, Suite 809 Professional Building I, Chicago, IL 60612, USA
,
A. Raza Rush Cancer Institute, 1725 West Harrison Street, Suite 809 Professional Building I, Chicago, IL 60612, USA
&
H.D. Preisler Rush Cancer Institute, 1725 West Harrison Street, Suite 809 Professional Building I, Chicago, IL 60612, USA
Pages 157-164 | Published online: 01 Jul 2009

  • Bos, J.L. (1989) "Ras oncogenes in human cancer: a review", Cancer Res. 49, 4682-4689.
  • Lyons, J., Janssen, J.W.G., Bartram, C., Layton, M. and Mufti, G.J. (1988) "Mutation of Ki-ras ann N-ras oncogenes in myelodysplastic syndromes", Blood 71, 1707-1712.
  • Yunis, J.J., Boot, A.J.M., Mayer, M.G. and Bos, J.L. (1989) "Mechanisms of ras mutation in myelodysplastic syndrome", Oncogene 4, 609-614.
  • Neubauer, A., Greenberg, P., Negrin, R., Ginzton, N. and Liu, E. (1994) "Mutations in the ras proto-oncogenes in patients with myelodysplastic syndromes", Leukemia 8, 638-641.
  • Bos, J.L. Velgan-de Vries, M., van der Eb, A.J., Janssen, J.W.G., Delwel, R., Lowenberg, B. and Colly, L.P. (1987) "Mutations in N-ras predominate in acute myeloid leukemia", Blood 69, 1237-1241.
  • Shen, W.P.V., Aldrich, T.H., Venta-Perez, G., Franza, B.R. and Furth, M.E. (1987) "Expression of normal and mutant ras proteins in human acute leukemia", Oncogene 1, 157-165.
  • Chang, E.H., Furth, M.K., Scolnick, K.M. and Lowy, U.R. (1982) "Tumorigenic transformation of mammalian cells induced by a normal human gene homologous to the oncogene of Harvey murine sarcoma virus", Nature 297, 479-483.
  • Khosravi-Far, R. and Der, C.J. (1994) "The ras signal transduction pathway", Cancer Metastasis Rev. 13, 67-89.
  • Feig, L.A. and Schaffhausen, B. (1994) "Signal transduction: the hunt for ras targets", Nature 370, 508-509.
  • Garcia, A.M., Rowell, C., Ackermann, K., Kowalczyk, J.J. and Lewis, M.D. (1993) "Peptidomimetic inhibitors of ras farnesylation and function in whole cells", J. Biol. Chem. 268, 18415-18418.
  • Kohl, N.K., Wilson, K.R., Mosser, S.D., Giuliani, E., DeSolms, S.J., Conner, M.W., Anthony, N.J., Holtz, W.J., Gomez, R.P., Lee, T.J., Smith, R.L., Graham, S.L., Hartman, G.D., Gibbs, J.B. and Oliff, A. (1994) "Protein farnesyltransferase inhibitors block the growth of ras-dependent tumors in nude mice", Proc. Natl Acad. Sci. 91, 9141-9145.
  • Sepp-Lorenzno, L., Ma, Z., Rands, E., Kohl, N.E., Gibbs, J.B., Oliff, A. and Rosen, N. (1995) "A peptidomimetic inhibitor of farnesyl: protein transferase blocks the anchorage dependent and independent growth of human tumor cell lines", Cancer Res. 55, 5302-5309.
  • Lerner, E.C., Qian, Y., Blaskovich, M.A., Fossum, R.D., Vogt, A., Sun, J., Cox, A.D., Der, C.J., Hamilton, A.D. and Sebti, S.M. (1995) "Ras CAAX peptidomimetic FTI-277 selectively blocks oncogenic ras signaling by inducing cytoplasmic accumulation of inactive ras-raf complexes", J. Biol. Chem. 270, 26802-26806.
  • Kohl, N.E., Omer, C.A., Conner, M.W., Anthony, N.J., Davide, J.P., DeSolms, S.J., Giuliani, E.A., Gomez, R.P., Graham, S.L., Hamilton, K., Handt, L.K., Hartman, G.D., Koblan, K.S., Kral, A.M., Miller, P.J., Mosser, S.D., O'Neill, T.J., Rands, E., Schaber, M.D., Gibbs, J.B. and Oliff, A. (1995) "Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic mice", Nat. Med. 1, 747-748.
  • Barrington, R.E., Subler, M.A., Rands, E., Omer, C.A., Miller, P.J., Hundley, J.E., Koester, S.K., Troyer, D.A., Bearss, D.J., Conner, M.W., Gibbs, J.B., Hamilton, K., Koblan, K.S., Mosser, S.D., O'Neill, T.J., Schaber, M.D., Senderak, E.T., Windle, J.J., Oliff, A. and Kohl, N.E. (1995) "A farnesyltransferase inhibitor induces tumor regression in transgenic mice harboring multiple oncogenic mutations by mediating alterations in both cell cycle control and apoptosis", Mol. Cell Biol. 18, 85-92.
  • Bennett, J.M. and Begg, C.B. (1981) "Eastern Cooperative Oncology Group study of the cytochemistry of adult acute myeloid leukemia by correlation of subtypes with response and survival", Cancer Res. 41, 4833-4837.
  • [I7] Messner, H.A. (1986) "Human leukemia: cell culture", Semin. Hematol. 23, 218-222.
  • Fauser, A.A. and Messner, H.A. (1979) "Proliferative state of human pluripotent hemopoietic progenitors (CFU-GEMM) in normal individuals and under regenerative conditions after bone marrow transplantation", Blood 54, 1197-1200.
  • McCormick, F. (1998) "Signal transduction: why ras needs rho", Nature 394, 220-221.
  • Maher, J., Baker, D., Dibb, N. and Roberts, I. (1996) "Mutant ras promotes haemopoietic cell proliferation and differentiation in a cell-specific manner", Leukemia 10, 83-90.
  • Zaker, F., Darley, R.L., Sabah, A.A. and Burnett, A.K. (1997) "Oncogenic ras genes impair erythroid differentiation of erythroleukaemia cells", Leuk. Res. 21, 635-640.
  • Darley, R.L., Hoy, T.G., Baines, P., Padua, R.A. and Burnett, A.K. (1997) "Mutant N-ras induces erythroid lineage dysplasia in human CD34+ cells", J. Exp. Med. 185, 1337-1347.
  • Gibbs, J.D. and Oliff, A. (1997) "The potential of farnesyltransferease inhibitors, as cancer chemo-therapeutics", Annu. Rev. Pharmacol. Toxicol. 37, 143-166.
  • Sepp-Lorenzino, L. Rosen, N. (1998) "A farnesyl-protein transferase inhibitor induces p21 expression and G1 block in p53 wild type tumor cells", J. Biol. Chem. 273, 20243-20251.
  • Lebowitz, P.F. and Prendergast, G.C. (1998) "Non-ras targets of farnesyltransferase inhibitors: focus on Rho", Oncogene 17, 1439-1445.
  • Tao, M., Li, B., Nayini, J. Andrews, C.B., Huang, R.-W., Yang, J., Devemy, E., Song, S., Venugopal, P. and Preisler, H.D. (2002) "SCF, IL-1ß, IL-1ra and GM-CSF in the bone marrow and serum of normal individuals and of AML and CML patients", Cytokine, In Press.
  • Puil, L., Liu, J., Gish, G., Mbamalu, G., Bowtell, D., Pelicci, P.G., Arlinghaus, R. and Pawson, T. (1994) "Bcr-Abl oncoproteins bind directly to activators of the ras signalling pathway", EMBO J. 13, 764-773.
  • Tauchi, T., Okabe, S., Miyazawa, K. and Ohyashiki, K. (1998) "The tetramerization domain-independent ras activation by BCR-ABL oncoprotein in hematopoietic cells", Int. J. Oncol. 12, 1269-1276.
  • Kurzrock, R. and Talpaz, M. (1991) "The molecular pathology of chronic myelogenous leukameia", Br. J. Haematol. 79, 34-37.
  • Warmuth, M., Danhauser-Riedl, S. and Hallek, M. (1999) "Molecular pathogenesis of chronic myeloid leukemia: implications for new therapeutic strategies", Ann. Hematol. 78, 49-64
  • Danhauser-Riedl, S., Warmuth, M., Druker, B.J., Emmerich, B. and Hallek, M. (1996) "Activation of Src kinases p53/56lyn and p59hck by p210bcrabl in myeloid cells", Cancer Res. 56, 3589-3596.
  • Raitano, A.B., Halpern, J.R., Humbuch, T.M. and Sawyers, C.L. (1995) "The Bcr-Abl leukemia oncogene activates Jun kinase and requires Jun for transformation", Proc. Natl Acad. Sci. 92, 11746-11750.
  • Rovera, G., Richard, B.A., Hudson, S., Bittenbender, S., Yamada, M., Tournay, O. and Preisler, H.D. (1989) "Point mutations in both transforming and non-transforming codons of the N-ras protocogene of Ph leukemias", Onoigene 4, 867-872.
  • Ge, Y. Li, Z.H., Marshall, M.S., Broxmeyer, H.E. and Lu, L. (1998) "Involvement of of H-ras in erythroid differentiation of TFl and humun umbilical cord blood CD34 cells", Blood Cells Mol. Dis24(2), 124-136.
  • Lu, L., Ge, Y., Li, Z.H., Dai, M.S. and Broxmeyer, H.E. (2000) "Enhancement of proliferation and differentiation of erythroid progenitors by co-transduction of erythropoietin receptor and H-ras cDNAS into single CD34(3 +) cord blood cells", Bane marrow Transplant. 26(8), 817-822.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.